N CDT Reagent 1 (3 × 0.9 mL) consists of a suspension of polystyrene particles coated with carbohydrate-deficient transferrin (< 0.017 g/L).\nN CDT Reagent 2 (3 × 0.9 mL) consists of a suspension of polystyrene particles coated with monoclonal anti-CDT antibodies (mouse) (< 0.009 g/L).\nN CDT Supplementary Reagent (3 × 2 mL) consists of a phosphate buffered saline solution with polyethylene glycol sorbitan monolaurate (5 g/L) and EDTA (< 0.2 mol/L).\nN CDT Standard SL (human) (3 × 1 mL) consists of a stabilized human serum matrix and carbohydrate-deficient transferrin. \nN CDT Control SL/1 (3 × 1 mL) and N CDT Control SL/2 (human) (3 × 1 mL) each consist of a stabilized human serum matrix and carbohydrate-deficient transferrin.

共有 1 個藥物證書使用此成份

申請商
西門子醫療設備股份有限公司 
適應症
含量
發證日期
2008-03-18